[ad#The Buzz Sponsor Ad]

Sapphire hires Dr. Matthew Croughan as new CTO

May 22, 2013
AlgaeIndustryMagazine.com

Dr. Matthew Croughan, new Sapphire Energy CTO

Dr. Matthew Croughan, new Sapphire Energy CTO

Sapphire Energy, Inc. has announced that Dr. Matthew Croughan will join the company as Chief Technology Officer. Dr. Croughan is a world renowned engineer and researcher in industrial bioprocessing, having most recently served as George B. and Joy Rathmann Professor and Director of the Amgen Bioprocessing Center at Keck Graduate Institute (KGI), a member of the Claremont Colleges Consortium. He has also served as a member of Sapphire Energy’s Scientific Advisory Board since June 2012. In the newly created role of CTO, Dr. Croughan will guide the company in its effort to refine and scale its technologies and algae-to-energy process as it moves towards commercial scale production of Green Crude oil.

“In just five years, Sapphire Energy has established itself as a world leader in advanced, algae-to-energy biotechnologies and agriculture, which is why we’re so pleased to welcome Dr. Croughan, a highly regarded expert in the bioprocessing field, to our leadership team,” said Cynthia ‘CJ’ Warner, CEO and chairman of Sapphire Energy. “He has extensive experience in helping companies optimize their biological products and processes to better achieve scalability and maximize yields. We’ve been fortunate to have him on our advisory board, and now, as our CTO, he’ll play an integral role as we move closer to commercializing Green Crude production.”

Dr. Croughan established the KGI Bioprocessing Center in 2006, and developed a unique program to recruit and educate the next generation of business leaders in bioprocessing. Leveraging the help of his colleagues in the biotechnology industry who often serve as adjunct faculty, he built the program into one of the largest masters-level programs in bioprocessing, with approximately 100 graduates to date.

Dr. Croughan recently won the Student Choice Faculty (Top Teaching) Award for 2012-2013, and will keep a limited role at KGI as Industry Professor while serving as CTO at Sapphire Energy. Since 1998, he also has worked as an independent consultant providing expert guidance on biopharmaceutical and biofuels process development and manufacturing to over 55 firms.

Previously, Dr. Croughan was the chief scientist for Genentech’s cell culture facility in Vacaville, CA, built for the production of therapeutic antibodies. Earlier in his career at Genentech, he developed the first licensed fed-batch cell culture process, a breakthrough platform technology now used throughout the biopharmaceutical industry, especially for the economical production of high-dose blockbuster antibodies. Dr. Croughan has a Ph.D. from MIT and a BS from UC Berkeley, both in chemical engineering.

More Buzz…

HOME Algae Industry Jobs

Copyright ©2010-2013 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
A new $1 million relationship between Michigan State University and ExxonMobil will expand research in the fundamental science to advance algae-based fuels. Dr. David Kra...
Glass tubing manufacturer SCHOTT, and Algatechnologies Ltd. (Algatech), a commercial algae producer and one of the largest manufacturers of natural astaxanthin, have part...
Tel Aviv, Israel-based UniVerve Ltd. has begun scaling-up its technological process for algae cultivation. The oil, which can be extracted with off-the-shelf wet extracti...
The Chesapeake Bay Seed Capital Fund, located in College Park, Maryland, has invested $150,000 into Manta Biofuel LLC, a company that produces crude oil from algae at a c...
The U.S. Department of Energy (DOE) has awarded Arizona State University (ASU) a three-year, $1 million grant to fund the Atmospheric Carbon Dioxide Capture and Membrane ...
Bloomberg reports that ANA Holdings Inc., Japan’s largest airline, plans to use a Euglena Co. biofuel made from algae. ANA will use a mix of about 10 percent of the algae...
Algatechnologies Ltd. has launched its AstaPure® 5% Natural Astaxanthin oleoresin, derived from Haematococcus pluvialis microalgae. This latest addition to the AstaPure f...
While researchers have long suspected that climate change will lead to stronger and more frequent algal blooms, a new fusion of climate models and watershed models has pr...
I’m an aquanaut teen. I was born in immersion in 2050 in an underwater farm called “Aequorea” off the coast of Rio de Janeiro. Bio-inspired, the farm draws its name from ...
Nevele, Belgium-based TomAlgae is developing freeze-dried microalgae for feed in shrimp hatcheries. The company has created its own microalgal “cultivar” and manufactures...
The new algae raceway testing facility, opening February 4 at Sandia National Laboratories in Livermore, California, paves a direct path between laboratory research and s...
Abigail Klein Leichman writes in ISRAEL21c that, in the rush to research algae-based technologies, Israel – as a startup nation itself – is at the forefront of much of th...